Results 211 to 220 of about 11,582,729 (334)

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Journal of Nuclear Medicine, 2017
M. Eiber, K. Herrmann, J. Calais, B. Hadaschik, F. Giesel, M. Hartenbach, T. Hope, R. Reiter, T. Maurer, W. Weber, W. Fendler   +10 more
semanticscholar   +1 more source

Molecular Imaging with Genetically Programmed Nanoparticles

, 2021
Donna E. Goldhawk
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Molecular imaging of psoriatic arthritis. [PDF]

Curr Opin Rheumatol
Groothuizen S, van der Laken CJ.
europepmc   +1 more source

European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma

European Journal of Nuclear Medicine and Molecular Imaging, 2019
D. Taïeb, R. Hicks, E. Hindié, B. Guillet, A. Avram, P. Ghedini, H. Timmers, Aaron T. Scott, S. Elojeimy, D. Rubello, I. Virgolini, S. Fanti, S. Balogova, N. Pandit-Taskar, K. Pacak   +14 more
semanticscholar   +1 more source

Molecular Imaging of Metastatic Potential [PDF]

, 2008
Paul T. Winnard, Arvind P. Pathak, Surajit Dhara, Steven Y. Cho, Venu Raman, Martin G. Pomper   +5 more
openalex   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma. [PDF]

BMJ Oncol
Weindler J, Ali M, Udovicich C, Hofman MS, Siva S.   +4 more
europepmc   +1 more source

Effect of molecular organization on the image histograms of polarization SHG microscopy

, 2012
Sotiris Psilodimitrakopoulos, Ivan Amat‐Roldan, Pablo Loza‐Álvarez, David Artigas   +3 more
openalex   +1 more source

In vitro prediction of the efficacy of molecularly targeted cancer therapy by Raman spectral imaging [PDF]

, 2015
Hesham K. Yosef, Laven Mavarani, Abdelouahid Maghnouj, Stephan A. Hahn, Samir F. El‐Mashtoly, Klaus Gerwert   +5 more
openalex   +1 more source